Identification of a Novel Bcl-2-interacting Mediator of Cell Death (Bim) E3 Ligase, Tripartite Motif-containing Protein 2 (TRIM2), and Its Role in Rapid Ischemic Tolerance-induced Neuroprotection*

  1. Robert Meller§**,2
  1. From the §Neuroscience Institute, Morehouse School of Medicine, Atlanta, Georgia 30310-1495,
  2. the Robert S. Dow Neurobiology Laboratories, Legacy Research, Portland, Oregon 97208-3950,
  3. the Royal College of Surgeons Ireland, Dublin 2, Eire,
  4. the Proteomics Facility, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, and
  5. the **Cancer Research Laboratories, Legacy Research, Portland, Oregon 97210-3077
  1. 2 To whom correspondence should be addressed: Robert Meller, Neuroscience Institute, Morehouse School of Medicine, 720 Westview Dr. S.W., Atlanta, GA 30310-1495. E-mail: rmeller{at}msm.edu.
  1. 1 Both authors contributed equally to this work.

Abstract

We have previously shown that the cell death-promoting protein Bcl-2-interacting mediator of cell death (Bim) is ubiquitinated and degraded following a neuroprotection-conferring episode of brief ischemia (preconditioning). Here, we identify the E3 ligase that ubiquitinates Bim in this model, using a proteomics approach. Using phosphorylated GST-Bim as bait, we precipitated and identified by mass spectrometry tripartite motif protein 2 (TRIM2), a RING (really interesting new gene) domain-containing protein. The reaction between TRIM2 and Bim was confirmed using co-immunoprecipitation followed by immunoblotting. We show that TRIM2 binds to Bim when it is phosphorylated by p42/p44 MAPK but does not interact with a nonphosphorylatable Bim mutant (3ABim). 12-O-tetradecanoylphorbol-13-acetate activation of p42/p44 MAPK drives Bim ubiquitination in mouse embryonic fibroblast cells and is associated with an increased interaction between TRIM2 and Bim. One hour following preconditioning ischemia, the binding of Bim to TRIM2 increased, consistent with the time window of enhanced Bim degradation. Blocking p42/p44 MAPK activation following preconditioning ischemia with U0126 or using the nonphosphorylatable 3ABim reduced the binding between Bim and TRIM2. Immunodepletion of TRIM2 from cell lysates prepared from preconditioned cells reduced Bim ubiquitination. Finally, suppression of TRIM2 expression, using lentivirus transduction of shRNAmir, stabilized Bim protein levels and blocked neuroprotection observed in rapid ischemic tolerance. Taken together, these data support a role for TRIM2 in mediating the p42/p44 MAPK-dependent ubiquitination of Bim in rapid ischemic tolerance.

Footnotes

  • * This work was supported, in whole or in part, by National Institutes of Health Grants NS50669 and NS59588 (to R. M.) and NS24728 and NS39016 (to R. P. S.). This work was also supported by National Institutes of Health/National Center for Research Resources/Research Centers at Minority Institutes Grants G12-RR03034 and U54 NS060659 (to Morehouse School of Medicine).

  • Graphic The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.

  • Received October 27, 2010.
  • Revision received March 21, 2011.
Table of Contents

Submit your work to JBC.

You'll be in good company.